Cameron Lionel Groome Sells 200,000 Shares of Microbix Biosystems Inc. (TSE:MBX) Stock

Microbix Biosystems Inc. (TSE:MBX) Director Cameron Lionel Groome sold 200,000 shares of the firm’s stock in a transaction dated Wednesday, January 22nd. The shares were sold at an average price of C$0.43, for a total value of C$86,500.00.

Microbix Biosystems Stock Down 3.8 %

TSE MBX traded down C$0.02 during trading on Thursday, hitting C$0.50. 375,883 shares of the company traded hands, compared to its average volume of 308,273. Microbix Biosystems Inc. has a 12 month low of C$0.29 and a 12 month high of C$0.52. The business has a fifty day simple moving average of C$0.37 and a 200 day simple moving average of C$0.35. The company has a current ratio of 6.62, a quick ratio of 5.57 and a debt-to-equity ratio of 22.68. The company has a market capitalization of C$68.35 million, a P/E ratio of 12.50 and a beta of 0.34.

About Microbix Biosystems

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.